| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |